10356-76-0 | 4-Amino-5-fluoro-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one

Packsize	Purity	Availability	Price	Discounted Price
1mg	95%	in stock	$7.00	$5.00
100mg	95%	in stock	$16.00	$11.00
1g	98%	in stock	$82.00	$58.00
5g	98%	in stock	$345.00	$242.00

Description

• Catalog Number: AD80335
• Chemical Name: 4-Amino-5-fluoro-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one
• CAS Number: 10356-76-0
• Molecular Formula: C9H12FN3O4
• Molecular Weight: 245.2077
• MDL Number: MFCD00077348
• SMILES: OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(nc1=O)N

Computed Properties

• Complexity: 398
• Covalently-Bonded Unit Count: 1
• Defined Atom Stereocenter Count: 3
• Heavy Atom Count: 17
• Hydrogen Bond Acceptor Count: 5
• Hydrogen Bond Donor Count: 3
• Rotatable Bond Count: 2
• XLogP3: -1.5

Literature

• Stability of 5-fluoro-2'-deoxycytidine and tetrahydrouridine in combination.

  AAPS PharmSciTech 20100301

• Mechanistic insights on the inhibition of c5 DNA methyltransferases by zebularine.

  PloS one 20100101

• 5-Fluorocytosine derivatives as inhibitors of deoxycytidine kinase.

  Bioorganic & medicinal chemistry letters 20091201

• Lead optimization and structure-based design of potent and bioavailable deoxycytidine kinase inhibitors.

  Bioorganic & medicinal chemistry letters 20091201

• DNA mismatch repair (MMR)-dependent 5-fluorouracil cytotoxicity and the potential for new therapeutic targets.

  British journal of pharmacology 20091001

• Concentrations of the DNA methyltransferase inhibitor 5-fluoro-2'-deoxycytidine (FdCyd) and its cytotoxic metabolites in plasma of patients treated with FdCyd and tetrahydrouridine (THU).

  Cancer chemotherapy and pharmacology 20080701

• Capecitabine: an evidence-based review of its effectiveness in the treatment of carcinoma of the pancreas.

  Core evidence 20070101

• Pharmacokinetics, metabolism, and oral bioavailability of the DNA methyltransferase inhibitor 5-fluoro-2'-deoxycytidine in mice.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20061215

• Role of the guanine N1 imino proton in the migration and reaction of radical cations in DNA oligomers.

  Journal of the American Chemical Society 20060405

• Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-2'-deoxycytidine.

  Molecular cancer therapeutics 20051001

• Covalent DNA display as a novel tool for directed evolution of proteins in vitro.

  Protein engineering, design & selection : PEDS 20040901

• Zebularine: a novel DNA methylation inhibitor that forms a covalent complex with DNA methyltransferases.

  Journal of molecular biology 20020823

• A supramicromolar elevation of intracellular free calcium ([Ca(2+)](i)) is consistently required to induce the execution phase of apoptosis.

  Cell death and differentiation 20020501

• Synthesis and anticancer and antiviral activities of various 2'- and 3'-methylidene-substituted nucleoside analogues and crystal structure of 2'-deoxy-2'-methylidenecytidine hydrochloride.

  Journal of medicinal chemistry 19910801

• Cellular differentiation, cytidine analogs and DNA methylation.

  Cell 19800501